Glucagon-like peptide 1 agonists for treatment of patients with type 2 diabetes who fail metformin monotherapy: systematic review and meta-analysis of economic evaluation studies.

BMJ Open Diabetes Research & Care
Bhavani Shankara BagepallyAmmarin Thakkinstian

Abstract

To conduct a systematic review and meta-analysis and to pool the incremental net benefits (INBs) of glucagon-like peptide 1 (GLP1) compared with other therapies in type 2 diabetes mellitus (T2DM) after metformin monotherapy failure. The study design is a systematic review and meta-analysis. We searched MEDLINE (via PubMed), Scopus and Tufts Registry for eligible cost-utility studies up to June 2018, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline. We conducted a systematic review and pooled the INBs of GLP1s compared with other therapies in T2DM after metformin monotherapy failure. Various monetary units were converted to purchasing power parity, adjusted to 2017 US$. The INBs were calculated and then pooled across studies, stratified by level of country income; a random-effects model was used if heterogeneity was present, and a fixed-effects model if it was absent. Heterogeneity was assessed using Q test and I2 statistic. A total of 56 studies were eligible, mainly from high-income countries (HICs). The pooled INBs of GLP1s compared with dipeptidyl peptidase-4 inhibitor (DPP4i) (n=10), sulfonylureas (n=6), thiazolidinedione (TZD) (n=3), and insulin (n=23) from HICs were US$4012.21 (...Continue Reading

References

May 5, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D A AschM T Mennuti
Jun 27, 2000·Diabetes Care·D C Klonoff, D M Schwartz
Jun 8, 2001·Statistics in Medicine·A R Willan, D Y Lin
May 20, 2003·PharmacoEconomics·Maria Raikou, Alistair McGuire
May 29, 2004·European Journal of Gastroenterology & Hepatology·Andrew R Willan
Jun 3, 2004·Annals of Internal Medicine·Ping ZhangK M Venkat Narayan
Jan 26, 2007·Journal of Managed Care Pharmacy : JMCP·John B WatkinsSean D Sullivan
Feb 2, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Michael E MinshallAndrew J Palmer
Jul 31, 2009·International Journal of Clinical Pharmacology and Therapeutics·M BrändleW J Valentine
Jun 24, 2011·The Journal of Clinical Endocrinology and Metabolism·Ralph A DeFronzo, Muhammad A Abdul-Ghani
Jul 2, 2011·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Gordon GoodallTatiana Dilla
Sep 3, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M J DaviesW J Valentine
Sep 26, 2012·International Journal of Technology Assessment in Health Care·Lan GaoShu-Chuen Li
Apr 30, 2013·Journal of Medical Economics·Louise Justesen HesselbjergKarin Dam Petersen
Oct 18, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Pedro Mezquita RayaWilliam J Valentine
Jun 21, 2014·Journal of Medical Economics·Katarina Steen Carlsson, Ulf Persson
Sep 13, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Aliasghar A KiadaliriKatarina Steen Carlsson
Dec 24, 2014·BMC Medical Research Methodology·Carlos CrespoMartín Ríos
Jan 4, 2015·BMJ : British Medical Journal·Larissa ShamseerUNKNOWN PRISMA-P Group
Mar 5, 2015·PharmacoEconomics·Jinsong GengYingyao Chen
Mar 7, 2015·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Antonio PérezWilliam J Valentine
Mar 17, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Yue ZhongPeter J Neumann
Mar 20, 2015·PharmacoEconomics·Till SeuringMarc Suhrcke
Sep 29, 2015·Journal of Medical Economics·Ronan RousselWilliam J Valentine
Nov 5, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·J F O'Mahony
Nov 21, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Charles Christian AdarkwahSilvia M A A Evers
Jan 7, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Barnaby HuntDonna Ashley

❮ Previous
Next ❯

Software Mentioned

ProQuest
Scopus
Excel
Wiley
IDegLira
STATA
WebPlotDigitizer

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.